| Date Filed | Type | Description |
| 06/09/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/08/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 05/19/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 13,500 options to buy
@ $17.11, valued at
$231k
|
|
| 08/15/2022 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Mind Medicine (MindMed) Inc.|
Txns:
| Granted 89,286 shares
@ $0
Granted 120,968 options to buy
@ $0
Granted 503,773 options to buy
@ $0 |
|
| 08/15/2022 |
3
| Bruhn Suzanne Louise (Director) has filed a Form 3 on Mind Medicine (MindMed) Inc. |
| 07/28/2022 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 24,310 options to buy
@ $6.93, valued at
$168.5k
|
|
| 07/28/2022 |
3
| Bruhn Suzanne Louise (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 06/21/2022 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $6.8, valued at
$102k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Avalo Therapeutics, Inc. |
| 10/04/2021 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 5,204 options to buy
@ $2.18, valued at
$11.3k
|
|
| 07/02/2021 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 3,465 options to buy
@ $3.27, valued at
$11.3k
|
|
| 06/30/2021 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
| 06/17/2021 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.56, valued at
$142.4k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 4,254 options to buy
@ $2.64, valued at
$11.2k
|
|
| 10/01/2020 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 4,325 options to buy
@ $2.275, valued at
$9.8k
|
|
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 28,100 options to buy
@ $8.89, valued at
$249.8k
|
|
| 06/02/2020 |
3
| Bruhn Suzanne Louise (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 04/27/2020 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.58, valued at
$129k
|
|
| 04/27/2020 |
3
| Bruhn Suzanne Louise (Director) has filed a Form 3 on Cerecor Inc. |
| 04/09/2020 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 5,250 shares
@ $0
Granted 15,750 options to buy
@ $15.63, valued at
$246.2k
|
|
| 04/09/2020 |
3
| Bruhn Suzanne Louise (Director) has filed a Form 3 on Retrophin, Inc. |
| 06/07/2019 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 12,400 options to buy
@ $6.33, valued at
$78.5k
|
|
| 08/13/2018 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 06/08/2018 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 18,400 options to buy
@ $10.28, valued at
$189.2k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/16/2017 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc. |
| 02/16/2017 |
3
| Bruhn Suzanne Louise (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 10/26/2016 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Unknown transaction of 48,437 shares
@ $9, valued at
$435.9k
Disposed/sold 8,330 shares
@ $9, valued at
$75k
Disposed/sold 90,000 options to buy
@ $5.13, valued at
$461.7k
Disposed/sold 30,680 options to buy
@ $5.49, valued at
$168.4k
|
|
|